Bristol Names Sigal To Head R&D Following Death Of James Palmer
Executive Summary
Bristol-Myers Squibb Pharmaceutical Research Institute President Elliott Sigal, MD, is taking the helm of Bristol's R&D efforts effective immediately, the company announced Oct. 28